TRTürkçe
ENEnglish
AZAzərbaycanca
UZO‘zbekcha
ARالعربية
FRFrançais
DEDeutsch
RUРусский
FDA scope: choose the correct US product pathway
Separate food, device, drug and cosmetic obligations using the actual product and facility activity.
Applicable route
Start with ingredients, intended use, label claims, manufacturing sites and US distribution. Food, medical devices, drugs and cosmetics have different routes. A business exporting several product types needs separate applicability decisions; one facility identifier does not establish a universal permission to sell.
Records and action
For food, evaluate facility registration and food-specific controls. For devices, evaluate establishment registration, listing and any required marketing authorization. For drugs, registration and listing are distinct from the lawful marketing route. For cosmetics, assess MoCRA registration/listing and relevant exemptions alongside safety and labeling.
Example and boundaries
Example: a face cream promoted as treating disease cannot be assessed solely from the word cosmetic on the invoice. Resolve claims and classification before preparing records. Kayra can arrange the scope and gaps; the regulated operator owns accurate submissions and FDA retains its statutory decisions.
Explore the subject
Use the guides to explore scope and practical questions in this field and find the detail relevant to your situation.
Tell us what you need and our specialists will contact you.
Provide the product branch, actual facility and specific record to be prepared. Kayra can scope preparation ; no agency decision or US-agent appointment is established here.
Scope and decision verification
Kayra Patent supports requirement analysis, document preparation and process coordination. Conformity or certification decisions belong to the independent body or public authority authorised under the applicable law and programme. Kayra cannot replace that decision or guarantee a certificate. Verify the issuer, scope, dates and any official register entry.